Form 4 for OGEN ORAGENICS INC
Accepted 2023-08-10 00:00:00 ET · period of report 2023-08-08 · accession 0001493152-23-027580 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-10 | 2023-08-08 | OGEN | Murphy Kimberly M | CEO, Pres, Dir | A - Grant | $0.00 | +25.0K | 25.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-08 | A | A | 25,000 | $0.00 | 25,000 | D | — | — | (F1) Represents an award of restricted stock of the Company's common stock under the Company's 2021 Equity Incentive Plan in connection with serving as the Company President and Chief Executive Officer with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months. |